For this issue of CJEM, we collaborated with their team to present “Buprenorphine/naloxone initiation and referral as a quality improvements intervention for patients who live with opiate use disorder”1 in a visual abstract format. Opioid use disorder is a major public health concern that accounts for a high number of potential years of life lost. Often, these patients use the ED as their primary contact with the healthcare system. The recommended treatment, buprenorphine/naloxone, …